Skip to main content
. 2012 Oct 24;7(10):e47511. doi: 10.1371/journal.pone.0047511

Table 1. Characteristics of Rotarix and RotaTeq vaccines for the prevention of rotavirus associated diarrhoea.

Rotarix Source RotaTeq Source
Manufacture Glaxo Smith Kline [11] Merck [12]
Doses 2 doses [11] 3 doses [12]
Vaccine virus G1P(8) [11] G1,G2,G3,G4,P1A(8) [12]
Concentration 106 CCID­ [11] 2.2×106 G1, 2.8×106 G2, 2.2×106 G3, 2.0×106 G4, 2.3×106 P1A(8) [12]
Cross potection G1, G3, G4, G9 [11] G1,G2,G3,G4 [12]
Administration Oral [11] Oral [12]
Timing of doses 6–24 weeks [11] 6–32 weeks [12]
Interval between doses Minimal 4 weeks [11] 4 to 10 weeks [12]
Store temp vial 2–8 degrees celcius [11] 2–8 degrees celcius [12]
Use within 24 hours [12] As soon as possible [12]
Package size vial 17.1cm3 per dose (full course: 34.2cm3) [38] 46.3cm3 per dose (full course: 138.9cm3) [38]
Vaccine Vial Monitor technology Yes [38] No [38]
Price $2.5 per dose, $5 full course [25] $3.5 per dose, $10.5 full course [26]
Shelf life 24 months [11] 24 months [12]
Adverse events Low [11] Low [12]
Thermostability Proven [37] Unproven